|
⚲
|
| Torrey Biotech & Health Sciences Fund LP | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001456607 |
| Sale | 1998-07-01 ($22.9 M Sold) |
| Fund | Hedge Fund |
| Phone | 2126447800 |
| Address | 505 Park Avenue New York, 10022 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2009-03-16 (D) |
| Exemption | 506, 3(c), 3(c)(1) |
| Minimum | $500,000 |
| Remaining | Indefinite |
| Duration | More than one year |
| Net Assets | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| James Torrey | Executive Officer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Miller Ann N
✚
|
0.0 | |
|
Miller Christopher Charles
✚
|
0.0 | |
|
Miller Clare
✚
|
0.0 | |
|
Miller Curtis John
✚
|
0.0 | |
|
McCamish Mark Anthony
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 55
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 57
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 58
✚
|
0.0 | |
|
EquityZen Growth Technology Fund LLC - Series 59
✚
|
0.0 | |
|
Active Value Fund Managers Ltd
✚
|
0.0 |